The OTC Stock Review is for investors with long time horizons who have the ability to ignore volatility in a small portion of their portfolio and focus on the individual situations. Investors who read our newsletter are primarily seeking an opportunity to make money in speculative stocks not yet discovered by Wall Street. Our objective is to offer ways for investors to expand their portfolios with lower-priced undervalued stocks and increase their knowledge of the investing in these types of companies.
We provide investors with a bi-monthly printed newsletter and offer email alerts throughout the market week. The OTC Stock Review provides a comprehensive review of financial market coverage. Our strategy with the OTC Stock Review is simple. We look for pure plays on our favorite fast-growing microcap situations in this often over-hyped, but under-researched part of the market, companies with less than $250 million in market capitalization. The OTC Stock Review uses a Bottom-Up approach to investing by focusing on a specific company rather than on the industry in which that company operates or on the economy as a whole. Using a combination of fundamental and technical criteria to identify growth stocks with tremendous upside potential, OTC Stock Review boasts 50 stock picks with returns between 25% and 1,000% in the last two years.